TFF Pharmaceuticals - Stock

TFF Pharmaceuticals P/E 2024

TFF Pharmaceuticals P/E

-0.26

Ticker

TFFP

ISIN

US87241J1043

WKN

A2PQ7K

As of Jun 16, 2024, TFF Pharmaceuticals's P/E ratio was -0.26, a -73.2% change from the -0.97 P/E ratio recorded in the previous year.

The TFF Pharmaceuticals P/E history

TFF Pharmaceuticals Aktienanalyse

What does TFF Pharmaceuticals do?

TFF Pharmaceuticals Inc is a biopharmaceutical company founded in 2018 and based in Austin, Texas. The company specializes in the development of inhalable drugs based on Thin Film Freezing technology. The history of TFF Pharmaceuticals began with the merger of two companies, Peloton Therapeutics and Infini Exploration. As a result of this fusion, the present-day TFF Pharmaceuticals was created. Since then, the company has experienced rapid growth and has become a leading provider of innovative inhalable medications. TFF Pharmaceuticals' business model includes the development and marketing of inhalable drugs based on patented Thin Film Freezing technology. This technology enables the production of medications in the form of nanoparticles that can be easily inhaled into the respiratory system. As a result, the drugs can directly reach the affected area of the lungs and have an immediate effect. TFF Pharmaceuticals' portfolio includes various areas such as oncology, respiratory diseases, infectious diseases, and rare diseases. The company is currently developing a variety of products in these areas, which have a significant market demand and can improve patients' quality of life. One example of a TFF Pharmaceuticals product is the inhalable medication Voriconazole-TFF. It is an innovative formulation of Voriconazole, an antifungal used for fungal infections. Voriconazole-TFF achieves a higher concentration in lung tissue and thus has a higher effectiveness than conventional Voriconazole products. The medication has been approved by the U.S. Food and Drug Administration (FDA) and is already on the market. Another example is the inhalable medication Tacrolimus-TFF, which is being developed for the treatment of lung transplant rejections. The Thin Film Freezing technology enables the production of Tacrolimus in nanoparticles that can directly reach the lungs and activate immunosuppression specifically there. TFF Pharmaceuticals closely collaborates with various partners to successfully market its products. These include pharmaceutical companies that take over the marketing of the products in different countries, as well as research institutes and medical facilities that work with TFF Pharmaceuticals to further develop its technology and products. Overall, TFF Pharmaceuticals is an innovative company specialized in the development of inhalable medications. With its patented Thin Film Freezing technology, the company has quickly made a name for itself and successfully brought its products to the market. TFF Pharmaceuticals' products have the potential to improve the lives of millions of patients worldwide, and the company will continue to play an important role in the pharmaceutical industry. TFF Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering TFF Pharmaceuticals's P/E Ratio

The Price to Earnings (P/E) Ratio of TFF Pharmaceuticals is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing TFF Pharmaceuticals's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of TFF Pharmaceuticals is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in TFF Pharmaceuticals’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about TFF Pharmaceuticals Stock

What is the price-to-earnings ratio of TFF Pharmaceuticals?

The price-earnings ratio of TFF Pharmaceuticals is currently -0.26.

How has the price-earnings ratio of TFF Pharmaceuticals changed compared to last year?

The price-to-earnings ratio of TFF Pharmaceuticals has increased by -73.2% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of TFF Pharmaceuticals high compared to other companies?

Yes, the price-to-earnings ratio of TFF Pharmaceuticals is high compared to other companies.

How does an increase in the price-earnings ratio of TFF Pharmaceuticals affect the company?

An increase in the price-earnings ratio of TFF Pharmaceuticals would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of TFF Pharmaceuticals affect the company?

A decrease in the price-earnings ratio of TFF Pharmaceuticals would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of TFF Pharmaceuticals?

Some factors that influence the price-earnings ratio of TFF Pharmaceuticals are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does TFF Pharmaceuticals pay?

Over the past 12 months, TFF Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, TFF Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of TFF Pharmaceuticals?

The current dividend yield of TFF Pharmaceuticals is .

When does TFF Pharmaceuticals pay dividends?

TFF Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of TFF Pharmaceuticals?

TFF Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of TFF Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is TFF Pharmaceuticals located?

TFF Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von TFF Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of TFF Pharmaceuticals from 6/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/16/2024.

When did TFF Pharmaceuticals pay the last dividend?

The last dividend was paid out on 6/16/2024.

What was the dividend of TFF Pharmaceuticals in the year 2023?

In the year 2023, TFF Pharmaceuticals distributed 0 USD as dividends.

In which currency does TFF Pharmaceuticals pay out the dividend?

The dividends of TFF Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von TFF Pharmaceuticals

Our stock analysis for TFF Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of TFF Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.